|
1.
|
Abrysvo
|
Trockensub 120 mcg c Solv mit Nadel
|
Fertspr 1 Stk
|
155.12
|
185.10
|
01.08.2025
|
|
|
L
|
Nein
|
69691001
|
Pfizer AG
|
Antigenum F praefusionis stabilitum RSV subgrupi A
|
21821
|
01.08.2025
|
A: 31.05.2028
|
|
|
|
08.08.
|
J07BX05
|
|
2.
|
Adacel
|
Inj Susp m Nadel
|
Fertspr 0.5 ml
|
18.70
|
36.75
|
01.06.2023
|
|
|
L
|
Nein
|
68317001
|
Sanofi-Aventis (Suisse) SA
|
Toxoidum diphtheriae
|
21407
|
01.06.2023
|
|
|
|
|
08.08.
|
J07AJ52
|
|
3.
|
Adacel-Polio
|
Inj Susp m Nadel
|
Fertspr 0.5 ml
|
24.00
|
42.50
|
01.06.2023
|
|
|
L
|
Nein
|
68110001
|
Sanofi-Aventis (Suisse) SA
|
Toxoidum diphtheriae
|
21408
|
01.06.2023
|
|
|
|
|
08.08.
|
J07CA02
|
|
4.
|
Bexsero
|
Inj Susp 0.5 ml
|
Fertspr 1 Dos
|
78.14
|
101.40
|
01.02.2024
|
|
|
L
|
Nein
|
65730003
|
GlaxoSmithKline AG
|
Proteinum fusionatum NHBA neisserii meningitidii B
|
21469
|
01.01.2023
|
|
|
|
|
08.08.
|
J07AH09
|
|
5.
|
Boostrix
|
Inj Susp 0.5 ml
|
Fertspr 1 Dos
|
17.30
|
35.25
|
30.09.2004
|
|
|
L
|
Nein
|
637003
|
GlaxoSmithKline AG
|
Toxoidum diphtheriae
|
17606
|
01.04.2001
|
|
|
|
|
08.08.
|
J07AJ52
|
|
6.
|
Boostrix Polio
|
Inj Susp 0.5 ml
|
Fertspr 1 Dos
|
24.86
|
43.45
|
01.12.2022
|
|
|
L
|
Nein
|
681003
|
GlaxoSmithKline AG
|
Toxoidum diphtheriae
|
18073
|
01.09.2004
|
|
|
|
|
08.08.
|
J07CA02
|
|
7.
|
Boostrix Polio
|
Inj Susp 0.5 ml (alt)
|
Fertspr 1 Dos
|
24.86
|
43.45
|
01.12.2022
|
|
|
L
|
Nein
|
681001
|
GlaxoSmithKline AG
|
Toxoidum diphtheriae
|
18073
|
01.09.2004
|
|
|
|
|
08.08.
|
J07CA02
|
|
8.
|
Comirnaty LP.8.1
|
Inj Disp 30 mcg/Dosis
|
Fertspr 0.3 ml
|
70.25
|
91.85
|
01.09.2025
|
|
|
L
|
Nein
|
70403001
|
Pfizer AG
|
SARS-CoV-2 LP.8.1 mRNA
|
21985
|
01.09.2025
|
A: 30.06.2026
|
|
|
|
08.08.
|
J07BN01
|
|
9.
|
Comirnaty LP.8.1
|
Inj Disp 30 mcg/Dosis
|
Fertspr 0.3 ml (Teilpackung)
|
|
77.05
|
|
|
|
L
|
Nein
|
70403002
|
Pfizer AG
|
SARS-CoV-2 LP.8.1 mRNA
|
21985
|
01.09.2025
|
A: 30.06.2026
|
|
|
|
08.08.
|
J07BN01
|
|
10.
|
Comirnaty LP.8.1
|
Inj Disp 30 mcg/Dosis
|
10 Fertspr 0.3 ml
|
702.46
|
770.65
|
01.07.2025
|
|
|
L
|
Nein
|
70403002
|
Pfizer AG
|
SARS-CoV-2 LP.8.1 mRNA
|
21985
|
01.09.2025
|
A: 30.06.2026
|
|
|
|
08.08.
|
J07BN01
|